Erschienen in:
01.08.2019 | Letter to the Editor
Comment on “Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis”
verfasst von:
Sinan Kardeş
Erschienen in:
Clinical Rheumatology
|
Ausgabe 11/2019
Einloggen, um Zugang zu erhalten
Excerpt
I read with intense attention the important study evaluating the efficacy of duloxetine and gabapentin in patients with knee osteoarthritis by Enteshari-Moghaddam et al. [
1]. This three-arm (i.e., duloxetine, gabapentin, and acetaminophen) study contributes to the knowledge on pharmacological treatments of knee osteoarthritis [
1]. I would like to comment on the study’s conclusion and also ask for clarification of discrepancy of the severity of osteoarthritis in patients included in the study [
1]. …